Thomas Garner - EVP, Chief Commercial Officer at Acadia Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Commercial Officer
Stock Symbol
ACAD on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Garner since 12/17/2023

Holdings reported by Thomas Garner for Acadia Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 45.4K $763K $16.81 Dec 9, 2024 Direct Common Stock
Stock Option (Right to Buy) 236K Dec 9, 2024 Direct Common Stock

Transactions reported by Thomas Garner for Acadia Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.